Inkjet-printed pharmaceutical formulations for preclinical studies – Presented by Anastasia Zakharyuta, Boehringer Ingelheim

Inkjet-printed pharmaceutical formulations for preclinical studies – Presented by Anastasia Zakharyuta, Boehringer Ingelheim Pharma GMBH Co & KG , at the 3D Medical Conference 5th edition, which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.

This presentation will focus on printable formulations for preclinical studies fabricated via piezo-actuated inkjet printing. Herein, incorporation of 2/3 D printing into preclinical formulation routine, as a replacement of techniques, such as homogenization and spray-drying is aimed to enhance quality and repeatability. Further challenges common to drug discovery are addressed via customized formulation design. Results of particulate printing targeting inhalation, intratracheal and oral administration routes, as well as solid oral dosage formulations designed suitable for administration to rodent species will be demonstrated.

About Anastasia Zakharyuta
Anastasia Zakharyuta currently works as a Post-Doctoral Researcher at Boehringer Ingelheim Pharma GMBH Co KG. She obtained her PhD in 2016 at Sabanci University, Biological Sciences and Bioengineering after an MSc in Material Science and Engineering.  She holds a BSc in Biochemirsty (Ege University).

About Boehringer Ingelheim Pharma GMBH Co & KG
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for.

Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned.

Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing

3D Medical Printing ConferenceAbout 3D Medical Conference
On January 30-31, 2018, MECC Maastricht, The Netherlands, will host a two-day event focused on 3D Medical Printing. Each day has different topics.

Day 1, Jan 30:

Day 2, Jan 31:

The audience, a mix of academics, medical professionals, business, technology, regulation and creatives, will get an excellent overview and insight in the medical tech developments from different perspectives.

Combination tickets are available and can be purchased on any of the conference websites.

 

Leave a Reply

Your email address will not be published. Required fields are marked *